News & Press Releases
NEWS
Presentation of Saturn at TVT – June 2023
View presentations on the novel SATURN TMVR technology with transseptal delivery, developed by Dr. Lauren S. Ranard in collaboration with Dr. Torsten Vahl, Dr. Paolo Denti, the staff from Skirball Center for Innovation, and InnovHeart R&D team, and presented at...
Presentation of Saturn at TCT – September 2022
Our technology has been presented at 2022 TCT held on September 16-19 in Boston, MA. Specifically, Dr. Paolo Denti, MD held a presentation about our Trans-apical FHU Study: 2-Years follow up, showing solid and effective data. Dr. Lauren S. Ranard, MD illustrated a...
Presentation of Saturn at TVT 2022 – June 2022
Our technology has been presented at 2022 TVT held on June 8-10 in Chicago, IL. Specifically, Dr. Paolo Denti, MD, spoke about "Trans-apical FHU Study: 1-Year follow up". Full video available here.
Presentation of Saturn at TVT – July 2021
Our technology has been presented at 2021 TVT to be held on July 20-22 in Miami, FL. Specifically, Dr. Torsten Vahl, MD, spoke about "Circumferential Mitral Leaflet Capture and Annular Resizing – InnovHeart".
Presentation of Saturn at EuroPCR – May 2021
Our Saturn Device was presented at 2021 EuroPCR held on May 18-20. Dr. Paolo Denti, MD, presented the earliest clinical results of the TransApical implant, while Dr. Torsten Vahl, MD, illustrated the advancements in the TransSeptal technology. Full videos available...
PRESS RELEASES
InnovHeart Elects Keith D. Dawkins MD as Chairman of the Board
Dr. Dawkins is transitioning from his position as a member of the InnovHeart Board which he joined in May of this year. Dr. Dawkins has more than 35 years experience as both a practicing phys ician and an executive within the medical device industry. He currently also...
InnovHeart Appoints Keith D. Dawkins, M.D., as Board Member
InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease, announces the appointment of veteran medical device executive Keith D. Dawkins, M.D., to a newly created position on its Board of Directors.